SCHEMBL24378833

SCHEMBL24378833

CC1CC2(CCN(CCO)CC2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.39
HSD11B1 P28845 1/20 0.38
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 1/20 0.36
SLC18A3 Q16572 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
ALOX15 P16050 1/20 0.32
KMT2A Q03164 3/20 0.32
LMNA P02545 2/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
PKM P14618 1/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
CARM1 Q86X55 1/20 0.31
PRMT6 Q96LA8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24378840 0.80 WNT1 (0.34) CYP1A2CYP2D6ALOX15CARM1PRMT6
SCHEMBL29326374 0.79 ALOX15 (0.45) KDM1AHSD11B1KDM4EALDH1A1SLC18A3
SCHEMBL15986991 0.77 ALOX15 (0.46) CYP1A2CYP2D6ALOX15
SCHEMBL24378839 0.77 HSD11B1 (0.42) KDM1AHSD11B1KDM4EALDH1A1CYP1A2
SCHEMBL15100017 0.77 TSHR (0.40) HSD11B1KDM4ESMN1; SMN2
SCHEMBL24378832 0.76 ALDH1A1 (0.52) ALDH1A1MAPK1CYP1A2CYP2D6ALOX15
SCHEMBL25923906 0.74 KDM1A (0.46) KDM1AHSD11B1KDM4EALDH1A1SLC18A3
SCHEMBL18820471 0.73 KDM4E (0.42) KDM1AHSD11B1KDM4EALDH1A1SLC18A3
SCHEMBL14414891 0.73 TSHR (0.32)
SCHEMBL22629445 0.73 SIGMAR1 (0.43) CYP1A2CYP2D6ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022083616-A1 QUINAZOLINE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF 贝达药业股份有限公司 2022-04-28 WO disclosed